| Profile | GDS1873 / 218772_x_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 335.089 | 67 |
| GSM40788 | control - Rep 2 | 127.831 | 39 |
| GSM40789 | control - Rep 3 | 202.467 | 53 |
| GSM40775 | androgen treated - Rep 1 | 156.923 | 45 |
| GSM40776 | androgen treated - Rep 2 | 367.587 | 70 |
| GSM40777 | androgen treated - Rep 3 | 285.349 | 64 |
| GSM40790 | estrogen treated - Rep 1 | 198.871 | 54 |
| GSM40791 | estrogen treated - Rep 2 | 446.907 | 74 |
| GSM40792 | estrogen treated - Rep 3 | 416.603 | 73 |
| GSM40784 | A + tamoxifen - Rep 1 | 376.134 | 70 |
| GSM40785 | A + tamoxifen - Rep 2 | 254.459 | 61 |
| GSM40786 | A + tamoxifen - Rep 3 | 436.161 | 74 |
| GSM40778 | A + anastrozole - Rep 1 | 176.643 | 49 |
| GSM40779 | A + anastrozole - Rep 2 | 453.556 | 74 |
| GSM40780 | A + anastrozole - Rep 3 | 210.794 | 55 |
| GSM40781 | A + letrozole - Rep 1 | 113.777 | 33 |
| GSM40782 | A + letrozole - Rep 2 | 233.91 | 58 |
| GSM40783 | A + letrozole - Rep 3 | 280.747 | 63 |